| Nose | |||||
|---|---|---|---|---|---|
| Nose / Nasal congestion | |||||
| ephedrine hydrochloride | NON-FORMULARY | ||||
|
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Solution for injection | |||||
| Ephedrine hydrochloride (Non-proprietary) | NON-FORMULARY | ||||
| pseudoephedrine hydrochloride | NON-FORMULARY | ||||
|
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Oral solution | |||||
| Galpseud (Thornton & Ross Ltd) | NON-FORMULARY | ||||
|
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Sudafed Non-Drowsy Decongestant (McNeil Products Ltd) | NON-FORMULARY | ||||
|
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| xylometazoline hydrochloride | NON-FORMULARY | ||||
|
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Spray | |||||
| Otrivine (Haleon UK Ltd) | NON-FORMULARY | ||||
|
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Sudafed Non-Drowsy Decongestant (McNeil Products Ltd) | NON-FORMULARY | ||||
|
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Nasal drops | |||||
| Otrivine (Haleon UK Ltd) | NON-FORMULARY | ||||
|
NHSE OTC coughs and cold
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Nose / Nasal infection | |||||
| mupirocin | FORMULARY PRODUCT | ||||
| Nasal ointment | |||||
| Bactroban (GlaxoSmithKline UK Ltd) | FORMULARY PRODUCT | ||||
| Nose / Nasal inflammation, nasal polyps and rhinitis | |||||
| azelastine hydrochloride | FORMULARY PRODUCT | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Eye drops | |||||
| Optilast (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
| Spray | |||||
| Rhinolast (Viatris UK Healthcare Ltd) | FORMULARY PRODUCT | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| beclometasone dipropionate | NON-FORMULARY | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Spray | |||||
| Beclometasone dipropionate (Non-proprietary) | NON-FORMULARY | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Beconase (GlaxoSmithKline UK Ltd, Omega Pharma Ltd) | NON-FORMULARY | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Nasobec (Teva UK Ltd) | NON-FORMULARY | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| betamethasone | FORMULARY PRODUCT | ||||
| budesonide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA708 |
|||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Spray | |||||
| Budesonide (Non-proprietary) | NON-FORMULARY | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| fluticasone | FORMULARY PRODUCT | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Spray | |||||
| Fluticasone (Non-proprietary) | FORMULARY PRODUCT | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Avamys (GlaxoSmithKline UK Ltd) | NON-FORMULARY | ||||
| Flixonase (GlaxoSmithKline UK Ltd, Haleon UK Ltd) | FORMULARY PRODUCT | ||||
|
NHS England OTC nasal sprays
NHS England guidance for CCGs on prescribing of OTC products (Mar-18):
General exceptions listed in guidance include long-term conditions; complex illness; patient group not licensed for OTC product; exceptional circumstances based on clinician’s judgement. See guidance for full list. |
|||||
| Nasofan (Teva UK Ltd) | NON-FORMULARY | ||||
| fluticasone with azelastine | FORMULARY PRODUCT | ||||
|
Allergic Rhinitis
The following guidelines are available on the Practice Portal: |
|||||
| Spray | |||||
| Dymista (Viatris UK Healthcare Ltd) | FORMULARY PRODUCT | ||||
| ipratropium bromide | FORMULARY PRODUCT | ||||
| Spray | |||||
| Rinatec (Sanofi Consumer Healthcare) | FORMULARY PRODUCT | ||||
| mometasone furoate | FORMULARY PRODUCT | ||||
| Spray | |||||
| Mometasone furoate (Non-proprietary) | FORMULARY PRODUCT | ||||
| Nasonex (Organon Pharma (UK) Ltd) | NON-FORMULARY | ||||
| triamcinolone acetonide | NON-FORMULARY | ||||
| Suspension for injection | |||||
| Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | NON-FORMULARY | ||||
| Spray | |||||
| Nasacort (Sanofi Consumer Healthcare) | NON-FORMULARY | ||||